Skip to main content
Shashank Udupa
  • Home
  • 7 Bar
  • Smallcase New
    • DisclosuresSEBI-mandated disclosures
    • Grievance RedressalComplaint process & SCORES
    • Grievance BoardMonthly disposal data
    • Investor CharterVision, rights & responsibilities
  • Blogs
  • Connect
Home7 BarSmallcaseBlogsConnect
Investor CharterDisclosuresGrievance RedressalGrievance BoardInvestor Charter
Blog

Fresh Takes on Money & Markets.

Short, direct posts about market behavior, investing psychology, and frameworks I personally follow.

3 Interesting Hospital Plays — cover image
2025-08-066 min read

3 Interesting Hospital Plays

A deep-dive on three hospital plays — Rainbow Children's Medicare, HCG, and KIMS — across paediatrics, oncology and pan-India multispecialty.

Read article
Top 3 Capex — 2025 — cover image
2025-07-306 min read

Top 3 Capex — 2025

Three companies investing aggressively today whose operating leverage could meaningfully play out over FY26 and beyond.

Read article
Windlas Biotech Ltd — The Pharma Beneficiary — cover image
2025-07-026 min read

Windlas Biotech Ltd — The Pharma Beneficiary

A focused look at one of India's leading CDMO operators in the generic pharma space, and why it sits at the intersection of multiple structural tailwinds.

Read article
Newsletter

Get the next post in your inbox.

Short, direct breakdowns on markets, frameworks, and the businesses worth watching. No spam, no fluff.

Shashank Udupa

Decoding finance, one insight at a time. SEBI Registered Research Analyst — INH000021207.

Explore
  • Home
  • 7 Bar Framework
  • Smallcase
  • F.L.U.I.D - Q
  • F.L.U.I.D - C
  • Blog
  • Contact
Community
  • YouTube (opens in new tab)
  • Instagram (opens in new tab)
  • X / Twitter (opens in new tab)
  • LinkedIn (opens in new tab)
  • Research Reports
  • Join Newsletter
Compliance
  • Disclosures
  • Grievance Redressal
  • Grievance Board
  • Investor Charter
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions
  • Cancellation Policy
Get in Touch
Office
501 Josvic, Greenfields,
Chembur, Mumbai — 400071

Support
support@shashankudupa.co.in

Phone +91 9611475970
Mon–Fri · 10am – 6pm IST

Grievance Officer
Shashank Sunil Udupa
support@shashankudupa.co.in
SEBI Registered Research Analyst Details
Registered Name: Shashank Sunil Udupa  |  Type of Registration: Individual  |  Reg. No.: INH000021207  |  Validity: June 23, 2025 — Perpetual
Registered Address: 501 Josvic, Greenfields, Chembur, Mumbai — 400071  ·  Tel: +91 9611475970  ·  Email: support@shashankudupa.co.in
Grievance Officer: Shashank Sunil Udupa · support@shashankudupa.co.in · +91 9611475970
SEBI Office:SEBI Bhavan BKC, Plot No. C4-A, ‘G’ Block, Bandra-Kurla Complex, Bandra (East), Mumbai — 400051, Maharashtra
SEBI Local Office: NBCC Complex, Office Tower-1, 8th Floor, Plate B, East Kidwai Nagar, New Delhi — 110023  ·  Board: +91-011-69012998  ·  Email: sebinro@sebi.gov.in
Tel: +91-22-26449000 / 40459000  ·  Fax: +91-22-26449019-22 / 40459019-22  ·  Email: sebi@sebi.gov.in ·  Toll Free Investor Helpline: 1800 22 7575
SEBI SCORES (opens in new tab) · SMARTODR (opens in new tab) · NISM Certificate (opens in new tab) · SEBI SCORES — Google Play (opens in new tab) · SEBI SCORES — App Store (opens in new tab)
Disclaimer:“Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. The securities quoted on the page above are for illustration only and are not recommendatory.”
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
© 2026 shashankudupa.co.in — All Rights Reserved.Decoding finance, one insight at a time.

Accessibility

Text size